吉林敖东：控股子公司获得聚乙烯醇滴眼液药品注册证书
吉林敖东(000623.SZ)公告称，公司控股子公司吉林敖东药业集团延吉股份有限公司收到国家药品监督管理局下发的聚乙烯醇滴眼液规格为1.4%(0.4ml：5.6mg)的《药品注册证书》 ... 该药品为非处方药，批准文号有效期至2030年03月17日。
媒体报道
吉林敖东：控股子公司获得聚乙烯醇滴眼液药品注册证书 36Kr/财联社/钛媒体
联邦制药聚乙烯醇滴眼液获批上市 医药魔方
#热门话题
BY Readhub
If riding a bucking bronco is your idea of fun, you’re going to love what the stock market has in store. Consider this past week’s ride a preview.The week’s action didn’t look like much, if you didn’t know better. The Dow Jones Industrial Average rose 213.12 points or 0.6%, while the S&P 500 advanced 0.5%, and the Nasdaq Composite ended little changed.
Importantly, that investor viewpoint is not new. It cycles in when conditions are right (and vice versa). It also brings the ineffective warnings of an overpriced market with it.Looking toward a good 2022 stock market, there is no apparent reason to expect these issues to change.
Readhub from us